09:45 AM EST - Amorfix Life Sciences : announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells. Amorfix Life Sciences
shares T.AMF are trading up $0.01 at $0.49.
